Skip Navigation
Skip to contents

대한신장학회


간행물 검색

현재 페이지 경로
  • HOME
  • 간행물
  • 간행물 검색
논문분류 춘계학술대회 초록집
제목 Discordance Between Mayo Imaging Classification and Actual eGFR Decline in Autosomal Dominant Polycystic Kidney Disease
저자 Seungyeup Han
출판정보 2026; 2026(1):
키워드 ADPKD, Mayo Image Classification, eGFR
초록 Objectives: The Mayo Imaging Classification (MIC) based on height-adjusted total kidney volume (htTKV) is widely used to predict disease progression in autosomal dominant polycystic kidney disease (ADPKD). However, it remains unclear whether imaging-based risk stratification reflects the actual rate of kidney function decline. This study evaluated the concordance between MIC and longitudinal eGFR decline and investigated clinical predictors of discordant classification. Methods: Among 1,575 patients enrolled between October 2019 and November 2025, 612 individuals with available htTKV data, ≥3 eGFR measurements, and ≥1 year follow-up were included. Individual eGFR slopes were estimated using linear mixed models with best linear unbiased prediction. Rapid progression was defined as an eGFR decline ≥2.5 mL/min/1.73 m²/year (Fig 1). The association between MIC and eGFR decline was evaluated using ordinary least squares regression (R²). Logistic regression analyses were performed to identify predictors of discordant classification. Covariates included age, sex, baseline eGFR, blood pressure, urinary albumin-to-creatinine ratio, hemoglobin, hypertension status, ARB use. Results: Among 612 patients, 81 and 276 were slow progressors with MIC 1A–1B and 1C–1E, while 34 and 221 were rapid progressors with MIC 1A–1B and 1C–1E, respectively. Scatter plot analysis demonstrated discordance between MIC and eGFR decline. (Fig 2). Among patients with rapid eGFR decline and MIC 1A–1B (under-classified), baseline eGFR, hemoglobin, and hypertension were significant predictors (OR 0.96, 0.59, and 2.6; AUC 0.875). Among patients without rapid decline but with MIC 1C–1E (over-classified), baseline eGFR and htTKV were significant predictors (OR 1.03 and 1.00; AUC 0.796). Incorporating clinical biomarkers improved risk stratification, increasing the model explanatory power from R² 0.07 to 0.33. Conclusion: The MIC remains a key prognostic tool in ADPKD. However, a subset of patients showed discordance between imaging-based classification and actual eGFR decline. Further studies are needed to better characterize these discordant groups and improve risk stratification.
원문(PDF) PDF 원문보기
위로가기